{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:12:28Z","timestamp":1783901548023,"version":"3.55.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["Overseas Research Fellowships"],"award-info":[{"award-number":["Overseas Research Fellowships"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["KAKENHI (21K15503)"],"award-info":[{"award-number":["KAKENHI (21K15503)"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009475","name":"Fuji Foundation for Protein Research","doi-asserted-by":"publisher","award":["Kaneko Narita Research Grant"],"award-info":[{"award-number":["Kaneko Narita Research Grant"]}],"id":[{"id":"10.13039\/100009475","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001695","name":"Japan Science and Technology Corporation","doi-asserted-by":"publisher","award":["CREST Program (JPMJCR21N3)"],"award-info":[{"award-number":["CREST Program (JPMJCR21N3)"]}],"id":[{"id":"10.13039\/501100001695","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["18\/SPP\/3522"],"award-info":[{"award-number":["18\/SPP\/3522"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["22\/PATH-S\/10875"],"award-info":[{"award-number":["22\/PATH-S\/10875"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA244660"],"award-info":[{"award-number":["R01CA244660"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"HORIZON EUROPE Framework Programme","doi-asserted-by":"publisher","award":["101136926 MULTIR"],"award-info":[{"award-number":["101136926 MULTIR"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Syst Biol Appl"],"DOI":"10.1038\/s41540-026-00710-6","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T09:07:24Z","timestamp":1776244044000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dual RAF inhibition outperforms RAF-MEK combinations for suppressing ERK signaling in KRAS mutant cells"],"prefix":"10.1038","volume":"12","author":[{"given":"Hiroaki","family":"Imoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Rauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayaka Ichikawa","family":"Nagasato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Kolch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleksii S.","family":"Rukhlenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris N.","family":"Kholodenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"710_CR1","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1038\/sj.onc.1202603","volume":"18","author":"CA Hall-Jackson","year":"1999","unstructured":"Hall-Jackson, C. A., Goedert, M., Hedge, P. & Cohen, P. Effect of SB 203580 on the activity of c-Raf in vitro and in vivo. Oncogene 18, 2047\u20132054 (1999).","journal-title":"Oncogene"},{"key":"710_CR2","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature08833","volume":"464","author":"G Hatzivassiliou","year":"2010","unstructured":"Hatzivassiliou, G. et al. RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth. Nature 464, 431\u2013435 (2010).","journal-title":"Nature"},{"key":"710_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.cell.2009.12.040","volume":"140","author":"SJ Heidorn","year":"2010","unstructured":"Heidorn, S. J. et al. Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF. Cell 140, 209\u2013221 (2010).","journal-title":"Cell"},{"key":"710_CR4","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nature08902","volume":"464","author":"PI Poulikakos","year":"2010","unstructured":"Poulikakos, P. I., Zhang, C., Bollag, G., Shokat, K. M. & Rosen, N. RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF. Nature 464, 427\u2013430 (2010).","journal-title":"Nature"},{"key":"710_CR5","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1016\/j.celrep.2015.08.014","volume":"12","author":"BN Kholodenko","year":"2015","unstructured":"Kholodenko, B. N. Drug resistance resulting from kinase dimerization is rationalized by thermodynamic factors describing allosteric inhibitor effects. Cell Rep. 12, 1939\u20131949 (2015).","journal-title":"Cell Rep."},{"key":"710_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ejca.2022.02.008","volume":"166","author":"M Salzmann","year":"2022","unstructured":"Salzmann, M. et al. MEK inhibitors for pre-treated, NRAS-mutated metastatic melanoma: a multi-centre, retrospective study. Eur. J. Cancer 166, 24\u201332 (2022).","journal-title":"Eur. J. Cancer"},{"key":"710_CR7","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1039\/C2MB25393C","volume":"9","author":"A Baljuls","year":"2013","unstructured":"Baljuls, A., Kholodenko, B. N. & Kolch, W. It takes two to tango - signalling by dimeric Raf kinases. Mol. Biosyst. 9, 551\u2013558 (2013).","journal-title":"Mol. Biosyst."},{"key":"710_CR8","doi-asserted-by":"crossref","unstructured":"Cook, F. A. & Cook, S. J. Inhibition of RAF dimers: It takes two to tango. Biochem. Soc. Trans. 49, 237\u2013251 (2021).","DOI":"10.1042\/BST20200485"},{"key":"710_CR9","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1038\/s43018-024-00800-6","volume":"5","author":"V Thatikonda","year":"2024","unstructured":"Thatikonda, V. et al. Co-targeting SOS1 enhances the antitumor effects of KRASG12C inhibitors by addressing intrinsic and acquired resistance. Nat. Cancer 5, 1352\u20131370 (2024).","journal-title":"Nat. Cancer"},{"key":"710_CR10","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.3390\/curroncol31040150","volume":"31","author":"LJ Ash","year":"2024","unstructured":"Ash, L. J. et al. KRAS: biology, inhibition, and mechanisms of inhibitor resistance. Curr. Oncol. 31, 2024\u20132046 (2024).","journal-title":"Curr. Oncol."},{"key":"710_CR11","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/s41417-021-00383-9","volume":"29","author":"J Liu","year":"2022","unstructured":"Liu, J., Kang, R. & Tang, D. The KRAS-G12C inhibitor: activity and resistance. Cancer Gene Ther. 29, 875\u2013878 (2022).","journal-title":"Cancer Gene Ther."},{"key":"710_CR12","doi-asserted-by":"crossref","unstructured":"Punekar, S. R., Velcheti, V., Neel, B. G. & Wong, K. K. The current state of the art and future trends in RAS-targeted cancer therapies. Nat. Rev. Clin. Oncol. 19, 637\u2013655 (2022).","DOI":"10.1038\/s41571-022-00671-9"},{"key":"710_CR13","doi-asserted-by":"crossref","unstructured":"Diehl, J. N. et al. Chapter Four - Targeting the ERK mitogen-activated protein kinase cascade for the treatment of KRAS-mutant pancreatic cancer. in Advances in Cancer Research (eds. O\u2019Bryan, J. P. & Piazza, G. A.) Vol. 153, 101\u2013130 (Academic Press, 2022).","DOI":"10.1016\/bs.acr.2021.07.008"},{"key":"710_CR14","doi-asserted-by":"publisher","first-page":"102238","DOI":"10.1016\/j.ctrv.2021.102238","volume":"99","author":"T Randic","year":"2021","unstructured":"Randic, T., Kozar, I., Margue, C., Utikal, J. & Kreis, S. NRAS mutant melanoma: towards better therapies. Cancer Treat. Rev. 99, 102238 (2021).","journal-title":"Cancer Treat. Rev."},{"key":"710_CR15","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.cub.2011.02.033","volume":"21","author":"MM McKay","year":"2011","unstructured":"McKay, M. M., Ritt, D. A. & Morrison, D. K. RAF inhibitor-induced KSR1\/B-RAF binding and its effects on ERK cascade signaling. Curr. Biol. 21, 563\u2013568 (2011).","journal-title":"Curr. Biol."},{"key":"710_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep38244","volume":"7","author":"M Kocha\u0144czyk","year":"2017","unstructured":"Kocha\u0144czyk, M. et al. Relaxation oscillations and hierarchy of feedbacks in MAPK signaling. Sci. Rep. 7, 1\u201315 (2017).","journal-title":"Sci. Rep."},{"key":"710_CR17","doi-asserted-by":"publisher","first-page":"109157","DOI":"10.1016\/j.celrep.2021.109157","volume":"35","author":"BN Kholodenko","year":"2021","unstructured":"Kholodenko, B. N., Rauch, N., Kolch, W. & Rukhlenko, O. S. A systematic analysis of signaling reactivation and drug resistance. Cell Rep. 35, 109157 (2021).","journal-title":"Cell Rep."},{"key":"710_CR18","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.3390\/cancers16162914","volume":"16","author":"A Goetz","year":"2024","unstructured":"Goetz, A. et al. Computational modeling of drug response identifies mutant-specific constraints for dosing panRAF and MEK inhibitors in melanoma. Cancers 16, 2914 (2024).","journal-title":"Cancers"},{"key":"710_CR19","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nrm1743","volume":"6","author":"W Kolch","year":"2005","unstructured":"Kolch, W. Coordinating ERK\/MAPK signalling through scaffolds and inhibitors. Nat. Rev. Mol. Cell Biol. 6, 827\u2013837 (2005).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"710_CR20","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nature25478","volume":"554","author":"H Lavoie","year":"2018","unstructured":"Lavoie, H. et al. MEK drives BRAF activation through allosteric control of KSR proteins. Nature 554, 549\u2013553 (2018).","journal-title":"Nature"},{"key":"710_CR21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00018-022-04296-0","volume":"79","author":"RC Maloney","year":"2022","unstructured":"Maloney, R. C., Zhang, M., Liu, Y., Jang, H. & Nussinov, R. The mechanism of activation of MEK1 by B-Raf and KSR1. Cell. Mol. Life Sci. 79, 281 (2022).","journal-title":"Cell. Mol. Life Sci."},{"key":"710_CR22","doi-asserted-by":"publisher","first-page":"276","DOI":"10.4161\/sgtp.2.5.17740","volume":"2","author":"MM Mckay","year":"2011","unstructured":"Mckay, M. M., Freeman, A. K. & Morrison, D. K. Complexity in KSR function revealed by Raf inhibitor and KSR structure studies. Small GTPases 2, 276\u2013281 (2011).","journal-title":"Small GTPases"},{"key":"710_CR23","doi-asserted-by":"publisher","first-page":"216029","DOI":"10.1016\/j.canlet.2022.216029","volume":"555","author":"W Zheng","year":"2023","unstructured":"Zheng, W. et al. SHP2 inhibition mitigates adaptive resistance to MEK inhibitors in KRAS-mutant gastric cancer through the suppression of KSR1 activity. Cancer Lett. 555, 216029 (2023).","journal-title":"Cancer Lett."},{"key":"710_CR24","doi-asserted-by":"publisher","first-page":"e2313137120","DOI":"10.1073\/pnas.2313137120","volume":"120","author":"BR Daley","year":"2023","unstructured":"Daley, B. R. et al. SOS1 and KSR1 modulate MEK inhibitor responsiveness to target resistant cell populations based on PI3K and KRAS mutation status. Proc. Natl. Acad. Sci. USA 120, e2313137120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"710_CR25","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1158\/1541-7786.MCR-24-0652","volume":"23","author":"D Chatterjee","year":"2025","unstructured":"Chatterjee, D. et al. KSR1 mediates small-cell lung carcinoma tumor initiation and cisplatin resistance. Mol Cancer Res. 23, 553\u2013566 (2025).","journal-title":"Mol Cancer Res."},{"key":"710_CR26","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.cels.2018.06.002","volume":"7","author":"OS Rukhlenko","year":"2018","unstructured":"Rukhlenko, O. S. et al. Dissecting RAF inhibitor resistance by structure-based modeling reveals ways to overcome oncogenic RAS signaling. Cell Syst. 7, 161\u2013179.e14 (2018).","journal-title":"Cell Syst."},{"key":"710_CR27","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.1093\/bioinformatics\/btw469","volume":"32","author":"LA Harris","year":"2016","unstructured":"Harris, L. A. et al. BioNetGen 2.2: Advances in rule-based modeling. Bioinformatics 32, 3366\u20133368 (2016).","journal-title":"Bioinformatics"},{"key":"710_CR28","doi-asserted-by":"crossref","unstructured":"Roskoski, R. Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes. Pharmacol. Res. 103, 26\u201348 (2016).","DOI":"10.1016\/j.phrs.2015.10.021"},{"key":"710_CR29","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrc4000","volume":"15","author":"CJ Caunt","year":"2015","unstructured":"Caunt, C. J., Sale, M. J., Smith, P. D. & Cook, S. J. MEK1 and MEK2 inhibitors and cancer therapy: the long and winding road. Nat. Rev. Cancer 15, 577\u2013592 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"710_CR30","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1158\/2159-8290.CD-20-0442","volume":"10","author":"MP Zafra","year":"2020","unstructured":"Zafra, M. P. et al. An in vivo kras allelic series reveals distinct phenotypes of common oncogenic variants. Cancer Discov. 10, 1654\u20131671 (2020).","journal-title":"Cancer Discov."},{"key":"710_CR31","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1158\/1541-7786.MCR-15-0203","volume":"13","author":"JC Hunter","year":"2015","unstructured":"Hunter, J. C. et al. Biochemical and structural analysis of common cancer-associated KRAS mutations. Mol. Cancer Res. 13, 1325\u20131335 (2015).","journal-title":"Mol. Cancer Res."},{"key":"710_CR32","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S0968-0004(00)88955-0","volume":"20","author":"BN Kholodenko","year":"1995","unstructured":"Kholodenko, B. N. & Westerhoff, H. V. The macroworld versus the microworld of biochemical regulation and control. Trends Biochem. Sci. 20, 52\u201354 (1995).","journal-title":"Trends Biochem. Sci."},{"key":"710_CR33","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/nrm1838","volume":"7","author":"BN Kholodenko","year":"2006","unstructured":"Kholodenko, B. N. Cell-signalling dynamics in time and space. Nat. Rev. Mol. Cell Biol. 7, 165\u2013176 (2006).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"710_CR34","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/0092-8674(95)90204-X","volume":"83","author":"M Therrien","year":"1995","unstructured":"Therrien, M. et al. KSR, a novel protein kinase required for RAS signal transduction. Cell 83, 879\u2013888 (1995).","journal-title":"Cell"},{"key":"710_CR35","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.1128\/MCB.24.10.4407-4416.2004","volume":"24","author":"RL Kortum","year":"2004","unstructured":"Kortum, R. L. & Lewis, R. E. The molecular scaffold KSR1 regulates the proliferative and oncogenic potential of cells. Mol. Cell Biol. 24, 4407\u20134416 (2004).","journal-title":"Mol. Cell Biol."},{"key":"710_CR36","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1101\/gad.962902","volume":"16","author":"F Roy","year":"2002","unstructured":"Roy, F., Laberge, G., Douziech, M., Ferland-McCollough, D. & Therrien, M. KSR is a scaffold required for activation of the ERK\/MAPK module. Genes Dev. 16, 427\u2013438 (2002).","journal-title":"Genes Dev."},{"key":"710_CR37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/bjc.2017.399","volume":"118","author":"DE Durrant","year":"2018","unstructured":"Durrant, D. E. & Morrison, D. K. Targeting the Raf kinases in human cancer: the Raf dimer dilemma. Br. J. Cancer 118, 3\u20138 (2018).","journal-title":"Br. J. Cancer"},{"key":"710_CR38","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.cell.2013.07.046","volume":"154","author":"J Hu","year":"2013","unstructured":"Hu, J. et al. Allosteric activation of functionally asymmetric RAF kinase dimers. Cell 154, 1036\u20131046 (2013).","journal-title":"Cell"},{"key":"710_CR39","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/nchembio.1257","volume":"9","author":"H Lavoie","year":"2013","unstructured":"Lavoie, H. et al. Inhibitors that stabilize a closed RAF kinase domain conformation induce dimerization. Nat. Chem. Biol. 9, 428\u2013436 (2013).","journal-title":"Nat. Chem. Biol."},{"key":"710_CR40","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41586-020-2760-4","volume":"588","author":"ZM Khan","year":"2020","unstructured":"Khan, Z. M. et al. Structural basis for the action of the drug trametinib at KSR-bound MEK. Nature 588, 509\u2013514 (2020).","journal-title":"Nature"},{"key":"710_CR41","doi-asserted-by":"publisher","first-page":"114710","DOI":"10.1016\/j.celrep.2024.114710","volume":"43","author":"T Sevrin","year":"2024","unstructured":"Sevrin, T. et al. Cell-specific models reveal conformation-specific RAF inhibitor combinations that synergistically inhibit ERK signaling in pancreatic cancer cells. Cell Rep. 43, 114710 (2024).","journal-title":"Cell Rep."},{"key":"710_CR42","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.trecan.2020.05.009","volume":"6","author":"V Subbiah","year":"2020","unstructured":"Subbiah, V., Baik, C. & Kirkwood, J. M. Clinical development of BRAF plus MEK inhibitor combinations. Trends Cancer 6, 797\u2013810 (2020).","journal-title":"Trends Cancer"},{"key":"710_CR43","doi-asserted-by":"publisher","first-page":"eadd7969","DOI":"10.1126\/sciadv.add7969","volume":"9","author":"A Mart\u00edn-Vega","year":"2023","unstructured":"Mart\u00edn-Vega, A. et al. Scaffold coupling: ERK activation by transphosphorylation across different scaffold protein species. Sci. Adv. 9, eadd7969 (2023).","journal-title":"Sci. Adv."},{"key":"710_CR44","doi-asserted-by":"publisher","first-page":"11022","DOI":"10.1073\/pnas.0901590106","volume":"106","author":"MM McKay","year":"2009","unstructured":"McKay, M. M., Ritt, D. A. & Morrison, D. K. Signaling dynamics of the KSR1 scaffold complex. Proc. Natl. Acad. Sci. USA 106, 11022\u201311027 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"710_CR45","first-page":"4232","volume":"63","author":"J Lozano","year":"2003","unstructured":"Lozano, J. et al. Deficiency of kinase suppressor of Ras1 prevents oncogenic Ras signaling in mice. Cancer Res. 63, 4232\u20134238 (2003).","journal-title":"Cancer Res"},{"key":"710_CR46","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3389\/fphys.2012.00475","volume":"3","author":"F Witzel","year":"2012","unstructured":"Witzel, F., Maddison, L. & Bl\u00fcthgen, N. How scaffolds shape MAPK signaling: what we know and opportunities for systems approaches. Front Physiol. 3, 475 (2012).","journal-title":"Front Physiol."},{"key":"710_CR47","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.3390\/biom13081212","volume":"13","author":"H Imoto","year":"2023","unstructured":"Imoto, H. et al. A combination of conformation-specific RAF inhibitors overcome drug resistance brought about by RAF overexpression. Biomolecules 13, 1212 (2023).","journal-title":"Biomolecules"},{"key":"710_CR48","doi-asserted-by":"publisher","first-page":"eabi6983","DOI":"10.1126\/science.abi6983","volume":"375","author":"NH Cho","year":"2022","unstructured":"Cho, N. H. et al. OpenCell: endogenous tagging for the cartography of human cellular organization. Science 375, eabi6983 (2022).","journal-title":"Science"},{"key":"710_CR49","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1074\/mcp.O111.014704","volume":"11","author":"M Wang","year":"2012","unstructured":"Wang, M. et al. PaxDb, a database of protein abundance averages across all three domains of life. Mol. Cell. Proteom. 11, 492\u2013500 (2012).","journal-title":"Mol. Cell. Proteom."},{"key":"710_CR50","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/pro.3307","volume":"27","author":"PJ Thul","year":"2018","unstructured":"Thul, P. J. & Lindskog, C. The human protein atlas: a spatial map of the human proteome. Protein Sci. 27, 233\u2013244 (2018).","journal-title":"Protein Sci."},{"key":"710_CR51","doi-asserted-by":"publisher","first-page":"30169","DOI":"10.1074\/jbc.274.42.30169","volume":"274","author":"BN Kholodenko","year":"1999","unstructured":"Kholodenko, B. N., Demin, O. V., Moehren, G. & Hoek, J. B. Quantification of short term signaling by the epidermal growth factor receptor. J. Biol. Chem. 274, 30169\u201330181 (1999).","journal-title":"J. Biol. Chem."},{"key":"710_CR52","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/msb.2009.19","volume":"5","author":"N Borisov","year":"2009","unstructured":"Borisov, N. et al. Systems-level interactions between insulin-EGF networks amplify mitogenic signaling. Mol. Syst. Biol. 5, 256 (2009).","journal-title":"Mol. Syst. Biol."},{"key":"710_CR53","doi-asserted-by":"publisher","first-page":"12841","DOI":"10.1073\/pnas.192442699","volume":"99","author":"BN Kholodenko","year":"2002","unstructured":"Kholodenko, B. N. et al. Untangling the wires: a strategy to trace functional interactions in signaling and gene networks. Proc. Natl. Acad. Sci. USA 99, 12841\u201312846 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"710_CR54","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/s41586-022-05194-y","volume":"609","author":"OS Rukhlenko","year":"2022","unstructured":"Rukhlenko, O. S. et al. Control of cell state transitions. Nature 609, 975\u2013985 (2022).","journal-title":"Nature"},{"key":"710_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scisignal.aab0990","volume":"8","author":"D Fey","year":"2015","unstructured":"Fey, D. et al. Signaling pathway models as biomarkers: patient-specific simulations of JNK activity predict the survival of neuroblastoma patients. Sci. Signal 8, 1\u201316 (2015).","journal-title":"Sci. Signal"},{"key":"710_CR56","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.cels.2018.10.013","volume":"7","author":"F Fr\u00f6hlich","year":"2018","unstructured":"Fr\u00f6hlich, F. et al. Efficient parameter estimation enables the prediction of drug response using a mechanistic pan-cancer pathway model. Cell Syst. 7, 567\u2013579.e6 (2018).","journal-title":"Cell Syst."},{"key":"710_CR57","doi-asserted-by":"publisher","first-page":"103944","DOI":"10.1016\/j.isci.2022.103944","volume":"25","author":"H Imoto","year":"2022","unstructured":"Imoto, H., Yamashiro, S. & Okada, M. A text-based computational framework for patient -specific modeling for classification of cancers. iScience 25, 103944 (2022).","journal-title":"iScience"},{"key":"710_CR58","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/msb.2013.1","volume":"9","author":"CF Lopez","year":"2013","unstructured":"Lopez, C. F., Muhlich, J. L., Bachman, J. A. & Sorger, P. K. Programming biological models in Python using PySB. Mol. Syst. Biol. 9, 646 (2013).","journal-title":"Mol. Syst. Biol."},{"key":"710_CR59","doi-asserted-by":"publisher","unstructured":"Sekar, J. A. P., Hogg, J. S. & Faeder, J. R. Energy-based modeling in BioNetGen. In Proceedings - 2016 IEEE International Conference on Bioinformatics and Biomedicine, BIBM 2016 1460\u20131467 https:\/\/doi.org\/10.1109\/BIBM.2016.7822739 (2017).","DOI":"10.1109\/BIBM.2016.7822739"},{"key":"710_CR60","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.cels.2020.10.002","volume":"11","author":"L Gerosa","year":"2020","unstructured":"Gerosa, L. et al. Receptor-driven ERK pulses reconfigure MAPK signaling and enable persistence of drug-adapted BRAF-mutant melanoma cells. Cell Syst. 11, 478\u2013494.e9 (2020).","journal-title":"Cell Syst."},{"key":"710_CR61","doi-asserted-by":"publisher","first-page":"e10988","DOI":"10.15252\/msb.202210988","volume":"19","author":"F Fr\u00f6hlich","year":"2023","unstructured":"Fr\u00f6hlich, F., Gerosa, L., Muhlich, J. & Sorger, P. K. Mechanistic model of MAPK signaling reveals how allostery and rewiring contribute to drug resistance. Mol. Syst. Biol. 19, e10988 (2023).","journal-title":"Mol. Syst. Biol."},{"key":"710_CR62","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nrm1498","volume":"5","author":"C Wellbrock","year":"2004","unstructured":"Wellbrock, C., Karasarides, M. & Marais, R. The RAF proteins take centre stage. Nat. Rev. Mol. Cell Biol. 5, 875\u2013885 (2004).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"710_CR63","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0962-8924(00)01741-4","volume":"10","author":"BN Kholodenko","year":"2000","unstructured":"Kholodenko, B. N., Hoek, J. B. & Westerhoff, H. V. Why cytoplasmic signalling proteins should be recruited to cell membranes. Trends Cell Biol. 10, 173\u2013178 (2000).","journal-title":"Trends Cell Biol."},{"key":"710_CR64","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1083\/jcb.200308060","volume":"164","author":"NI Markevich","year":"2004","unstructured":"Markevich, N. I., Hoek, J. B. & Kholodenko, B. N. Signaling switches and bistability arising from multisite phosphorylation in protein kinase cascades. J. Cell Biol. 164, 353\u2013359 (2004).","journal-title":"J. Cell Biol."},{"key":"710_CR65","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1158\/2159-8290.CD-24-0139","volume":"14","author":"MB Ryan","year":"2024","unstructured":"Ryan, M. B. et al. The Pan-RAF\u2013MEK nondegrading molecular glue NST-628 is a potent and brain-penetrant inhibitor of the RAS\u2013MAPK pathway with activity across diverse RAS-and RAF-driven cancers. Cancer Discov. 14, 1190\u20131205 (2024).","journal-title":"Cancer Discov."},{"key":"710_CR66","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.molcel.2004.11.055","volume":"17","author":"MK Dougherty","year":"2005","unstructured":"Dougherty, M. K. et al. Regulation of Raf-1 by direct feedback phosphorylation. Mol. Cell 17, 215\u2013224 (2005).","journal-title":"Mol. Cell"},{"key":"710_CR67","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1128\/MCB.00569-09","volume":"30","author":"DA Ritt","year":"2010","unstructured":"Ritt, D. A., Monson, D. M., Specht, S. I. & Morrison, D. K. Impact of feedback phosphorylation and Raf heterodimerization on normal and mutant B-Raf signaling. Mol. Cell Biol. 30, 806\u2013819 (2010).","journal-title":"Mol. Cell Biol."},{"key":"710_CR68","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1128\/MCB.26.6.2262-2272.2006","volume":"26","author":"LK Rushworth","year":"2006","unstructured":"Rushworth, L. K., Hindley, A. D., O\u2019Neill, E. & Kolch, W. Regulation and role of Raf-1\/B-Raf heterodimerization. Mol. Cell Biol. 26, 2262\u20132272 (2006).","journal-title":"Mol. Cell Biol."},{"key":"710_CR69","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nature08314","volume":"461","author":"T Rajakulendran","year":"2009","unstructured":"Rajakulendran, T., Sahmi, M., Lefran\u00e7ois, M., Sicheri, F. & Therrien, M. A dimerization-dependent mechanism drives RAF catalytic activation. Nature 461, 542\u2013545 (2009).","journal-title":"Nature"},{"key":"710_CR70","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1002\/j.1460-2075.1994.tb06424.x","volume":"13","author":"DR Alessi","year":"1994","unstructured":"Alessi, D. R. et al. Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1. EMBO J. 13, 1610\u20131619 (1994).","journal-title":"EMBO J."},{"key":"710_CR71","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","volume":"17","author":"P Virtanen","year":"2020","unstructured":"Virtanen, P. et al. SciPy 1.0: fundamental algorithms for scientific computing in Python. Nat. Methods 17, 261\u2013272 (2020).","journal-title":"Nat. Methods"},{"key":"710_CR72","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0076-6879(01)33067-7","volume":"333","author":"SJ Taylor","year":"2001","unstructured":"Taylor, S. J., Resnick, R. J. & Shalloway, D. Nonradioactive determination of Ras-GTP levels using activated Ras interaction assay. Methods Enzymol. 333, 333\u2013342 (2001).","journal-title":"Methods Enzymol."},{"key":"710_CR73","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676\u2013682 (2012).","journal-title":"Nat. Methods"},{"key":"710_CR74","doi-asserted-by":"crossref","unstructured":"Schneider, C. A., Rasband, W. S., & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods. 9, 671\u2013675 (2012).","DOI":"10.1038\/nmeth.2089"}],"container-title":["npj Systems Biology and Applications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41540-026-00710-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41540-026-00710-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41540-026-00710-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:02:15Z","timestamp":1783900935000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41540-026-00710-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["710"],"URL":"https:\/\/doi.org\/10.1038\/s41540-026-00710-6","relation":{},"ISSN":["2056-7189"],"issn-type":[{"value":"2056-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"29 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"O.S.R., W.K. and B.N.K. filed a patent application (WO2019224216A1) on inhibitor combinations to inhibit kinases whose activation includes dimerization or oligomerization. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"106"}}